Home › Steatotic Liver Disease › California › San Francisco
Steatotic Liver Disease clinical trials in San Francisco, CA
5 studies for Steatotic Liver Disease are looking for participants at sites in and around San Francisco (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
RecruitingPhase 2
- UCSF/Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco
- UCSF Medical Center, San Francisco
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
RecruitingPhase 3
- Quest Clinical Research, San Francisco
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
RecruitingPhase 3
- Akero Clinical Study Site, San Francisco
- Akero Clinical Study Site, San Francisco
Bicalutamide Therapy in Young Women With NAFLD and PCOS
RecruitingPhase 1
- University of California San Francisco, San Francisco
Androgens and NAFLD Longitudinal Cohort Study
RecruitingObservational study
- University of California San Francisco, San Francisco
About Steatotic Liver Disease
Steatotic liver disease, formerly called fatty liver disease, happens when too much fat builds up in your liver. Learn about the causes and treatments.
More about Steatotic Liver Disease on MedlinePlus
Steatotic Liver Disease trials in other cities
- San Antonio, TX17 studies
- Miami, FL16 studies
- New York City, NY16 studies
- San Diego, CA14 studies
- Austin, TX13 studies
- Houston, TX13 studies
- Richmond, VA12 studies
- Chandler, AZ10 studies
- Tucson, AZ10 studies
- St. Louis, MO9 studies
- Dallas, TX9 studies
- Orlando, FL9 studies
Other studies in San Francisco
- Prostate Cancer45 studies
- Breast Cancer43 studies
- Non-Small Cell Lung Cancer36 studies
- Cancer (all types)35 studies
- Heart Failure29 studies
- Metastatic Cancer28 studies
- Lung Cancer22 studies
- Melanoma22 studies
- Pancreatic Cancer20 studies
- Ovarian Cancer19 studies
- Colorectal Cancer18 studies
- Cardiovascular Disease18 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.